CARE Ratings
Financial Data & Stock Exchanges · CARERATING
Small CapFinancial ServicesMature Stable
Mehul Pandya
Managing Director & Group CEO · Transactional
Company DNA
Bureaucratic
About
CARE Ratings is a Small Cap company in the Financial Services sector, listed on NSE as CARERATING. With a market cap of ₹5K Cr and revenue of ₹402 Cr, it is currently in the Mature Stable phase. Known for its Bureaucratic culture and Traditionalist approach to innovation, the company operates at a Steady-Marathon pace. Highly regulated industry requiring strict adherence to compliance, internal committee governance, and rigorous analytical processes. Its strategic mandate: Mandate focuses on restoring credibility and strengthening internal governance frameworks amidst intensifying regulatory scrutiny.
FAQ
What kind of company is CARE Ratings?
CARE Ratings is a Small Cap Financial Services company (CARERATING) in the Mature Stable phase with a market cap of ₹5K Cr. It is classified as Bureaucratic in culture.
What is CARE Ratings's culture and work environment like?
CARE Ratings has a Bureaucratic culture with Traditionalist innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. Highly regulated industry requiring strict adherence to compliance, internal committee governance, and rigorous analytical processes.
Who leads CARE Ratings?
CARE Ratings is led by Mehul Pandya (Managing Director & Group CEO), a Transactional leader with 30 years of experience.
What are CARE Ratings's financials?
CARE Ratings reported revenue of ₹402 Cr in FY25 with a 5-year revenue CAGR of 17.7%. Operating margin: 35.9%. Market cap: ₹5K Cr.
Culture & Strategy
CultureBureaucratic
InnovationTraditionalist
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandTrusted
LifecycleMature Stable
Highly regulated industry requiring strict adherence to compliance, internal committee governance, and rigorous analytical processes.
Mandate
Mandate focuses on restoring credibility and strengthening internal governance frameworks amidst intensifying regulatory scrutiny.
Mandate focuses on restoring credibility and strengthening internal governance frameworks amidst intensifying regulatory scrutiny.
Financials
Revenue FY25₹402 Cr
PAT FY25₹137 Cr
Rev CAGR 5Y17.7%
OPM35.9%
NPM34.1%
ROE17%
ROCE16.8%
P/E29.6
Fwd P/E24.3
P/B5.5
D/E2.9
Mkt Cap₹5K Cr
Promoter17.3%
Institutional35%
Similar Culture
Could You Lead CARE Ratings?
Take the Genome Benchmark →